The DOI matches its Crossref record; 249 of the 249 references it cites were found in a registry or an index.
Clinical and Pathophysiological Overview of Acinetobacter Infections: a Century of Challenges
Open accessAbstract
SUMMARY: Acinetobacter is a complex genus, and historically, there has been confusion about the existence of multiple species. The species commonly cause nosocomial infections, predominantly aspiration pneumonia and catheter-associated bacteremia, but can also cause soft tissue and urinary tract infections. Community-acquired infections by Acinetobacter spp. are increasingly reported. Transmission of Acinetobacter and subsequent disease is facilitated by the organism's environmental tenacity, resistance to desiccation, and evasion of host immunity. The virulence properties demonstrated by Acinetobacter spp. primarily stem from evasion of rapid clearance by the innate immune system, effectively enabling high bacterial density that triggers lipopolysaccharide (LPS)–Toll-like receptor 4 (TLR4)-mediated sepsis. Capsular polysaccharide is a critical virulence factor that enables immune evasion, while LPS triggers septic shock. However, the primary driver of clinical outcome is antibiotic resistance. Administration of initially effective therapy is key to improving survival, reducing 30-day mortality threefold. Regrettably, due to the high frequency of this organism having an extreme drug resistance (XDR) phenotype, early initiation of effective therapy is a major clinical challenge. Given its high rate of antibiotic resistance and abysmal outcomes (up to 70% mortality rate from infections caused by XDR strains in some case series), new preventative and therapeutic options for Acinetobacter spp. are desperately needed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–249 of 249
Inhaled colistin as monotherapy for multidrug-resistant gram (−) nosocomial pneumonia: A case series
Falagas, M. E., Siempos, I. Ι., Rafailidis, P. I., Korbila, I. P., Ioannidou, E., & Michalopoulos, A. S. (2009) · Respiratory Medicine · doi:10.1016/j.rmed.2008.11.018 · Cited by 56
Lin, C.-C., Liu, T.-C., Kuo, C.-F., Liu, C.-P., & Lee, C.-M. (2010) · Journal of Microbiology Immunology and Infection · doi:10.1016/s1684-1182(10)60050-3 · Cited by 56
Toll-Like Receptor 9 Contributes to Defense against Acinetobacter baumannii Infection
Noto, M. J., Boyd, K. L., Burns, W. J., Varga, M. G., Peek, R. M., & Skaar, E. P. (2015) · Infection and Immunity · doi:10.1128/iai.00410-15 · Cited by 56
Ng, T. M., Teng, C. B., Lye, D. C., & Apisarnthanarak, A. (2013) · Infection Control and Hospital Epidemiology · doi:10.1086/674387 · Cited by 54
CpaA a novel protease fromAcinetobacter baumanniiclinical isolates deregulates blood coagulation
Tilley, D., Law, R., Warren, S., Samis, J. A., & Kumar, A. (2014) · FEMS Microbiology Letters · doi:10.1111/1574-6968.12496 · Cited by 54
Taneja, N., Singh, G., Singh, M., & Sharma, M. (2011) · PubMed · Cited by 53
D’Arezzo, S., Capone, A., Petrosillo, N., & Visca, P. (2009) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2009.02668.x · Cited by 53
Liu, L.-L., Ji, S., Ruan, Z., Fu, Y., Fu, Y., Wang, Y., & Yu, Y. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04574-14 · Cited by 53
Martinez, T., Martínez, I., Vázquez, G. J., Aquino, E. E., & Robledo, I. E. (2016) · Journal of Medical Microbiology · doi:10.1099/jmm.0.000289 · Cited by 53
Hamidian, M., & Hall, R. M. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt312 · Cited by 52
Agodi, A., Barchitta, M., Quattrocchi, A., Maugeri, A., Aldisio, E., Marchese, A. E., Mattaliano, A. R., & Tsakris, A. (2015) · Antimicrobial Resistance and Infection Control · doi:10.1186/s13756-015-0087-y · Cited by 52
Microbiologic study of the pathogens isolated from wound culture among Wenchuan earthquake survivors
Tao, C., Kang, M., Chen, Z., et al. (2009) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2008.11.009 · Cited by 51
Song, J. Y., Cheong, H. J., Choi, W. S., Heo, J. Y., Noh, J. Y., & Kim, W. J. (2011) · Journal of Medical Microbiology · doi:10.1099/jmm.0.029439-0 · Cited by 51
Transferrin-mediated iron sequestration as a novel therapy for bacterial and fungal infections
Bruhn, K. W., & Spellberg, B. (2015) · Current Opinion in Microbiology · doi:10.1016/j.mib.2015.07.005 · Cited by 48
Self-citationde Breij, A., Eveillard, M., Dijkshoorn, L., van den Broek, P. J., Nibbering, P. H., & Joly‐Guillou, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030673 · Cited by 48
Tuon, F. F., Rocha, J. L. L., & Merlini, A. B. (2015) · Journal of Medical Microbiology · doi:10.1099/jmm.0.000144 · Cited by 48
de Léséleuc, L., Harris, G., KuoLee, R., Xu, H. H., & Chen, W. (2013) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2013.12.002 · Cited by 47
Stress Response and Virulence Functions of the Acinetobacter baumannii NfuA Fe-S Scaffold Protein
Zimbler, D. L., Park, T. M., Arivett, B. A., Penwell, W. F., Greer, S. M., Woodruff, T. M., Tierney, D. L., & Actis, L. A. (2012) · Journal of Bacteriology · doi:10.1128/jb.00213-12 · Cited by 47
Nosocomial A cinetobacter pneumonia: Treatment and prognostic factors in 356 cases
Özvatan, T. Ş., Akalın, H., Sınırtaş, M., Ocakoğlu, G., Yılmaz, E., Heper, Y., Girgin, N. K., İşçimen, R., & Kahveci, F. (2015) · Respirology · doi:10.1111/resp.12698 · Cited by 47
Mathai, A. S., Oberoi, A., Madhavan, S., & Kaur, P. (2012) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2011.12.002 · Cited by 46
The structure of the polysaccharide isolated from Acinetobacter baumannii strain LAC-4
VINOGRADOV, E. V., MacLean, L. L., Xu, H. H., & Chen, W. (2014) · Carbohydrate Research · doi:10.1016/j.carres.2014.03.001 · Cited by 45
Henig, O., Weber, R., Hoshen, M. B., Paul, M., German, L., Neuberger, A., Gluzman, I., Berlin, A., Shapira, C., & Balicer, R. D. (2015) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-015-2452-4 · Cited by 42
Mosqueda, N., Espinal, P., Cosgaya, C., Viota, S., Plasensia, V., Álvarez-Lerma, F., Montero, M., Gómez, J., Horcajada, J. P., Vilà, J., et al. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01486-13 · Cited by 42
Diabetic murine models for Acinetobacter baumannii infection
Luo, G., Spellberg, B. J., Gebremariam, T., Bolaris, M., Lee, H., Fu, Y., French, S. W., & Ibrahim, A. S. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks050 · Cited by 39
Self-citationPailhories, H., Belmonte, O., Kempf, M., Lemarié, C., Cuziat, J., Quinqueneau, C., Ramont, C., Joly‐Guillou, M., & Eveillard, M. (2015) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2015.05.012 · Cited by 38
Editorial Commentary: Polymyxin-Resistant Acinetobacter baumannii: Urgent Action Needed
Pogue, J. M., Cohen, D. A., & Marchaim, D. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ044 · Cited by 38
Hamidian, M., & Hall, R. M. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt488 · Cited by 38
Kang, C.-H., Tsai, C., Wu, T.-H., Wu, H.-Y., Chung, M., Chen, C., Huang, Y., Liu, S., Liao, D., Niu, C.-K., et al. (2013) · Pediatric Pulmonology · doi:10.1002/ppul.22750 · Cited by 38
Causes of Infection after Earthquake, China, 2008
Wang, Y., Peng, H., Lu, B., Yu, H., Huang, W., Hou, H., & Dai, K. (2010) · Emerging infectious diseases · doi:10.3201/eid1606.091523 · Cited by 37
Inhaled Colistin for Treatment of Pneumonia due to Colistin-Only-SusceptibleAcinetobacter baumannii
Choi, H. K., Kim, Y. K., Kim, H. Y., & Uh, Y. (2013) · Yonsei Medical Journal · doi:10.3349/ymj.2014.55.1.118 · Cited by 36
Flamm, R. K., Castanheira, M., Streit, J. M., & Jones, R. N. (2016) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2016.03.019 · Cited by 34
Warner, W. A., Kuang, S. N., Hernandez, R., Chong, M. C., Ewing, P. J., Fleischer, J. A., Meng, J., Chu, S., Terashita, D. M., English, L., et al. (2016) · BMC Infectious Diseases · doi:10.1186/s12879-016-1526-y · Cited by 32
Kenyon, J. J., Speciale, I., Hall, R. M., & Castro, C. D. (2016) · Carbohydrate Research · doi:10.1016/j.carres.2016.07.016 · Cited by 32
Smani, Y., López-Rojas, R., Domínguez-Herrera, J., Docobo-Pérez, F., Martí, S., Vilà, J., & Pachón, J. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03695.x · Cited by 30
Vaccines for Acinetobacter baumannii: Thinking “out of the box”
Pérez, F., & Bonomo, R. A. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.03.031 · Cited by 30
Self-citationGenetic tools for manipulating Acinetobacter baumannii genome: an overview
Biswas, I. (2015) · Journal of Medical Microbiology · doi:10.1099/jmm.0.000081 · Cited by 29
Claeys, K. C., Fiorvento, A. D., & Rybak, M. J. (2014) · Infectious Diseases and Therapy · doi:10.1007/s40121-014-0051-9 · Cited by 29
Sinha, N., Niazi, M., & Lvovsky, D. (2014) · Case Reports in Infectious Diseases · doi:10.1155/2014/705279 · Cited by 25
Ben, R.-J., Yang, M., Hsueh, J.-C., Shiang, J.-C., & Chien, S. (2011) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2011.05.014 · Cited by 23
Signature Motifs Identify an Acinetobacter Cif Virulence Factor with Epoxide Hydrolase Activity
Bahl, C. D., Hvorecny, K. L., Bridges, A. A., Ballok, A. E., Bomberger, J. M., Cady, K. C., O’Toole, G. A., & Madden, D. R. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.518092 · Cited by 21
Genetic Manipulation of Acinetobacter baumannii
Jacobs, A. C., Thompson, M. G., Gebhardt, M. J., Corey, B. W., Yıldırım, S., Shuman, H. A., & Zurawski, D. V. (2014) · Current Protocols in Microbiology · doi:10.1002/9780471729259.mc06g02s35 · Cited by 20
Loss of Mitochondrial Protein Fus1 Augments Host Resistance to Acinetobacter baumannii Infection
Hood, M. I., Uzhachenko, R. V., Boyd, K. L., Skaar, E. P., & Ivanova, A. V. (2013) · Infection and Immunity · doi:10.1128/iai.00771-13 · Cited by 18
Some immunological properties of lipopolysaccharide from Acinetobacter baumannii
García, A., Salgado, F., SOLAR, H., González, C., Raúl Zemelman, Z., & OñTATE, A. (1999) · Journal of Medical Microbiology · doi:10.1099/00222615-48-5-479 · Cited by 17
Rock, C., Harris, A. D., Johnson, J. K., et al. (2015) · Infection Control and Hospital Epidemiology · doi:10.1017/ice.2015.68 · Cited by 17
Clinical implications of glycoproteomics forAcinetobacter baumannii
Kinsella, R. L., Scott, N. E., & Feldman, M. F. (2014) · Expert Review of Proteomics · doi:10.1586/14789450.2015.987756 · Cited by 15
Fiester, S. E., Nwugo, C. C., Penwell, W. F., Neary, J. M., Beckett, A. C., Arivett, B. A., Schmidt, R. E., Geiger, S. C., Connerly, P. L., Menke, S. M., et al. (2015) · Infection and Immunity · doi:10.1128/iai.02925-14 · Cited by 15
Choi, I. S., Lee, Y. J., Wi, Y. M., Kwan, B. S., Jung, K. H., Hong, W. P., & Kim, J. M. (2016) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2016.05.011 · Cited by 15
Nonaka, Y., Nagae, M., Omae, T., Yamamoto, S., Horitani, R., Maeda, D., & Yoshinaga, T. (2014) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2013.12.011 · Cited by 9
Business Aspects of Infectious Diseases
Tenenbaum, M. J., & Petrak, R. M. (2002) · Clinical Infectious Diseases · doi:10.1086/324577 · Cited by 8
Cited by
Uncovering the mechanisms of Acinetobacter baumannii virulence
Harding, C. M., Hennon, S. W., & Feldman, M. F. (2018) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2017.148 · Cited by 1,026
Ayoub Moubareck, C., & Hammoudi Halat, D. (2020) · Antibiotics · doi:10.3390/antibiotics9030119 · Cited by 627
The Mechanisms of Disease Caused by Acinetobacter baumannii
Morris, F. C., Dexter, C., Kostoulias, X., Uddin, M. I., & Peleg, A. Y. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.01601 · Cited by 360
Acinetobacter baumannii Resistance: A Real Challenge for Clinicians
Vázquez-López, R., Solano-Gálvez, S. G., Juárez Vignon-Whaley, J. J., Abello Vaamonde, J. A., Padró Alonzo, L. A., Rivera Reséndiz, A., Muleiro Álvarez, M., Vega López, E. N., Franyuti-Kelly, G., Álvarez-Hernández, D. A., et al. (2020) · Antibiotics · doi:10.3390/antibiotics9040205 · Cited by 296
New Treatment Options against Carbapenem-Resistant Acinetobacter baumannii Infections
Isler, B., Doi, Y., Bonomo, R. A., & Paterson, D. L. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01110-18 · Cited by 293
Self-citation
Metadata
- Authors
- Wong, D., Nielsen, T. B., Bonomo, R. A., Pantapalangkoor, P., Luna, B., & Spellberg, B.
- Venue
- Clinical Microbiology Reviews
- Publisher
- American Society for Microbiology
- Published
- 2017-01
- Volume
- 30
- Issue
- 1
- Pages
- 409-447
- ISSN
- 0893-8512 (ISSN-L)
- 1098-6618
- OpenAlex
- W2578361705
- Cited by
- 1,170
- References
- 249
- FWCI
- 30.88
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.